Search Login Register
moxifloxacin
(Avelox)
Summary
Also Known As:
Avelox; 1-cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Actira; Avalox; BAY 12-8039 Show All >>
Networked: 1073
relevant articles (159 outcomes,
249 trials/studies)
for this Drug
Key Diseases for which moxifloxacin is
Relevant
-
Infection
:
47 outcomes 51 studies in 274 results
-
Pneumonia (Pneumonitis)
:
16 outcomes 35 studies in 101 results
-
Endophthalmitis (Ophthalmia)
:
9 outcomes 9 studies in 57 results
-
Chronic Bronchitis
:
8 outcomes 23 studies in 51 results
-
Respiratory Tract Infections (Respiratory Tract Infection)
:
8 outcomes 14 studies in 64 results
Show All >>
Drugs Related to moxifloxacin
-
Ofloxacin (Levofloxacin)
-
gatifloxacin (Zymar)
-
Ciprofloxacin (Cipro)
-
Fluoroquinolones
-
7- ((3R)- aminohexahydro- 1H- azepin- 1- yl)- 8- chloro- 1- cyclopropyl- 6- fluoro- 1,4- dihydro- 4- oxo- 3- quinolinecarboxylic acid
-
Amoxicillin (Wymox)
-
Rifampin (Rifampicin)
-
Clarithromycin (Biaxin)
-
Metronidazole (Metric)
-
Vancomycin
Show All >>
Therapies Related to moxifloxacin
-
Topical Administration
-
Drug Therapy (Chemotherapy)
-
Phacoemulsification
-
Intravitreal Injections
-
Root Planing
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.